{"ticker": {"uuid": "a581f76a-1b19-440f-b26a-ae46ebdae052", "symbol": "AAPG", "name": "Ascentage Pharma Group International", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Ascentage Pharma (AAPG) Edges Higher, Testing Key Resistance Zone - Trend Reversal Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMGQ5OVpkTW4tNjFIOWVLa1VqSlByU1N4Q29qU3gxUXdzbS1ua2o3SzhZWTNkamJ3WXRTN0l0anZnb0NSTEtrV0IwZmxtdEQtc0xnajVBWkpXSlp2YVV1YmhfamNxOGhKSXdGVkk5b2xYX25oYWJBOHIzWldMV3U0aUpqZWk0NlhleURyTU1PM2UxNFo4a1E1NHI1V1ZkaFp6YkZkejNXZXRoa3o2SFE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-09T18:40:40+00:00", "published_display": "09 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxObHU0RE1IRWdidDZJYmZhR1JNcnl2MXY3TUVwMVFSa1E0TURieGM1Ym1mNmJLT0dVQy1DY3BNUGROcjlXSDVYMmdmWlVKcExJenA3SWpkTWdPSTVkMXdacTRUWjltS1ZKX2plX2wxMmZiZFZpYjAxelZCZ2k2N2poNjZ6SEhVWmNNZkQwemtwVXVZZG8ySXdCel9qWGV3QV96dk9iWno5eWlhZDVFcmY5SXg5Y25FRno1U2VWUWd5eEU5VS1ZSXB3SVQ2Mmw0NTZqX0xZZDlfZ2dHdnpQbzhtbnhjU2o1Ukh5a29PcnJyS003dw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-07-09T13:03:00+00:00", "published_display": "09 Jul 2026 13:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPYWRNdzRqN1Z2STE1cnNSNnBtbGhDVWprWmxyYnRIX1RjekhKY0wwTmhlMFVXSFZGWTJwczVuMEFRNG5tcmxrakJaZWE2MkIzaWl3cHFuVW4tNzBGcmFCT2J2TmkxdDFQU1BkeXhZY3ZDVldFT0dxMkN5SHFzT1o3MGZ0UlRQRllGaWgtNGhQcVhrSHJGM2tEQUR5eWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQSHB1TVdpZVBQUTZxaDlWQjQtVnFLUmZ3SUVNbk95RW1GRHhoUndfaGt2NUdkUE1BbWgtRERWYk0yUG5RdUN2X1FmMFFyWEFtcDYzT0k2QWlRdjBPdFdKSFAyU2MzNG8tRExwdFNiUl9ESzVGWHRKQXhBU3g1SUxGM01ma1VsZlpsNTRFRE5oWmstUFFtQy1aSVRvdmpYZURvZEQwWnZfNHBfNDNYRXR3SDVSZDJZZHBYR1RKclhvMHpkaVdla0pZbTZtNkRneVpEdXdqdG9zYjdIQTJsWWh0MW1B?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International Unsponsored ADR Actuals & Estimates (NASDAQ:AAPG)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPQkZlUGtnSXIxNHQ0Y2pVbkh6R2I1djN2YUxKSU43QU0yZzgxbkFYTjB6MVVhR2UzY0NOem5iTlZ2Z0ZuWXJoVTltS3ItSG9wOUQ5X2c4c0Z0N0JDUFY3clYtMFgzVzM2YlMwS3RyVjNjRFMxNjNXS3RRMi1nN1dwY1dtM1lGQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T08:27:26+00:00", "published_display": "26 Jun 2026 08:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (AAPG) Hovers Near Resistance as Traders Await Catalysts - NAAIM Exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQeGhJa2UtY28wQ0oxYmtmNW5sTEZURlc3bFdiUmVvN2dWZXBTMHVXNFRXaWE4Ym5ESC1ybndJN2VrOEpfdnNndktVeE9sdHZyUnJCQTNkVHFldEdLZFA5bnU4eGxTNzdKbGJabGZDenFYTExsNkJ1dldHTC05TGRjMmVlQ2t5NnVTam83YWJkeTVMVHEtZEEyS0M4VnRWTVlBcE9nTU1wMjg4NklHNXJXWjFzVUQ2dw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-multiple-clinical-233000837.html", "source_name": "GlobeNewswire", "published_at": "2026-06-14T23:30:00+00:00", "published_display": "14 Jun 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B. Riley Initiates Ascentage Pharma Group International at Buy With $45 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/b-riley-initiates-ascentage-pharma-113838263.html", "source_name": "MT Newswires", "published_at": "2026-06-10T11:38:38+00:00", "published_display": "10 Jun 2026 11:38", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNLVg3MHdZSkRGQUc1QkV2SUdwcmdraEU4Y0ZZa3NKODZ5Ml94RTVhUHcyMDBMcllCQ2Fma19uLXREV3NKSkhFeWtFRXFQRVVPWktVTXpwdDZoY3hFZUEzUVk2SGl3eUozOXlweXI1UmVMMklWNHJYdFNqSlhadHNhZ2xLT3RqdzNoRjZzempIajNWM1ctNGtvVkNzY0hvcFFJdzdtdG9pUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-data-olverembatinib-233000707.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-first-dataset-233000569.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-updated-clinical-233000091.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNMjgwWWlCbjR2U0V4eVpZc0FLMG9OSWoxcldJY1BCaWNEbnNjSUo3dHZKanNqQktpWmo0VnpNYlQxMTk1WFRjNjFXdnd6Wm5EWDA1Wkt1V0dZX1p6UHBxQmc1ZVZENzVONXFJLV9TM0V5UWVBMUxkSjczeUgyM0xxSEpsdFk5ZldTRVV2eHM5elhpcndhaVNFdGJQaWg5R2owbER2WjAteU42S3E2OThjWjJNd2wyaEhObWVQeUZBeUFsQW01d0ZEYjczQXFCU0lDdHVrN0hmRFRUVWlhaVRmZFRXQXlfMTQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Ascentage Pharma: Interview With Co-Founder & CEO Dr. Dajun Yang About The Global Hematology-Oncology Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1uMVItSWJpa1BJUS1SNWczVXY4YS1xMjg2THF4VTJsdG9WaWRLSF84UnFPWkVNallRZWlrMU1hQ1MwLU1QVmZ3aUEyZnFJR3lhejNBX3dmaUtfN3EyMmhSbkg4UVFWRmc4WGVCNlYzOWttY0xCRWZV0gF8QVVfeXFMUHpYYnpoLWxqc2Z1WTZGSDBDTXIxWjVGZ3NMNFZValZQMnVUamcxdkVsb1lHRVhMZERFdFFpV1ZTY0JRdG9OMGZINnBfeWJmN1QzT0szUnktaTd0UTB1b2pYTksyMlVzUk8xQmRIWVp1dTBVY2x2YUtYeGEzVA?oc=5", "source_name": "Pulse 2.0", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMkx3dXpVekVwcXpzNFFqZlRDdlE2dkliMGJGVUxld1BqZjhVLUt5aVJzVERaZjlMM0lJQ1RnTlRYb2pMLVpFd29ELWNlcks2U1JIMUNOUmRpNHJKY3hIcFE0Q2ZVRk9vbDZvNnEtMHpKdlRWRkdONEItbHUtaWFEVGZFOFN2cXNSZzVKZUhiRmVuUVcwdHgxOERqcGVleWljVjVEaThR?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAJBVV95cUxQZjJFWnc5cjFaTkR0R0xaeTFVVWRGS1BfNHdzbmh0SUFYdTJNSEJDR0pneGNfUTViTlpvSVVrTVlpXzU2ZEVFdGJFME5Gdll5VGFGdzBiMWxCUDZlYVVZdGtvQk55RWhBOFdfc09sZ2kxNnU5X244RGNFYnJNRDF5dEo1UE1hci1CVzZyeDZneWlLWTNXUHJjVXZnc1phWmRJRkVjNEJUTnFzRVNnYU5VZWxEMm9IVmhFWTJyeTF6TV9mSlh6ZUVvWlV5Q3NOc2pWaVFwTl9iYmJldUZocUJJTTJqUEo2TnN6cHRjT3hPWXJuZl9FLU5MbXJfRTFpSzNoQkVHdW9Oa3NwT0Q3RTJGc0V5T0xycThSMkZRUUU4eTh3T3RyQ1Y0bm01TFBGc3dXV0FxNlAzVmtoRjFvaEFjdm9Zblc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYSnZYMURPZEpZNW90bEZrSkNzNWp4aHVRT1hMRkxUN25wRi1nZFlNYWpCSEpiS0JNNFh2YmctQnlCT3VlN0hNQnpUdDM2U3BaMzRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T15:42:33+00:00", "published_display": "25 Apr 2025 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQeW5MS1NkQUtUTHBMRlRpaUdmRVVSR0twQU5kVnlNR0txMWZrbVF2MThLZkcyQ1FDbHhIdWNuaVhUQ29jUUZxZW1YNWQxU2J6dXlwOEU5V1gzQkJPZWM4a200Nlc5elBZWnMxMnBOOWdORWdkQlIwVUhSOE1wV3czbmJtR21oYzA?oc=5", "source_name": "Market source", "published_at": "2025-03-27T07:00:00+00:00", "published_display": "27 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Ascentage Pharma Group International - Unsponsored ADR (AAPG)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE16eGJ1dEJoYkRNb2lFQ096RVdfSWsxcmNaZHlmNWU2eFh5d1JybXpMQzFFTElzM0NkTVNNWXhIbHFidmVzOWdiYVBSR0JhRndXOEJheUU5VW94R3YzdEFGajJFamUyR0dsbDdwZHdIT3lvLVNaZWh3bg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-02-26T00:20:12+00:00", "published_display": "26 Feb 2025 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1ZLVhpaW5CWFNMUlBvUlpsMm51TER1VmJ2Z0swQ3VrMjY0ZWN6eTBEZDRIMEVZMjBiZExDUzlNcGdJS0pBaERrZWtORTRBYmNLWTE3UVpVeUNHMFdRTFhmaGJKaEplQQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-02-08T15:07:42+00:00", "published_display": "08 Feb 2025 15:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage prices first biotech IPO of 2025, raising $126M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMUNPSEJxZVpOa3RUMm80SGJBSXozeGxrd2UtU19JZUMyRnV0bzRJRGNkVHJraG5rbC1fR1gyT2tCREtvcGdhYmtYTVlfMy1JMlZ3X0ZmZG9ZWlgycWZGaVpqTW1NbHE0VTlXMklUN1JTVkxjbXhVVi1KRlJHM3RmMjMycVFuZ0ZLZGhn?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma soars on deal with cancer drug competitor", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPUHRFcWJ1QkNzUDNPUGVjbkNkbng5Ty1oSG1adl9jRWpiZTBHR0tiVzJrTEhySFZReTAyTHc5OXg2NU5NTmFzaEt0RWUwZkxmYlVVWlpOVVhENFNrWTVxT1Fnck9aNDJzU2l2ZmRjZnltaExBaWlEenZwTG5zRDQxVGwyZnE3SFJpZTBRNWd5VQ?oc=5", "source_name": "thebambooworks.com", "published_at": "2024-06-27T07:00:00+00:00", "published_display": "27 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQaFZ5b0V4Z0tpX1ZOdXpHZTFPbk96QzJLYVFJang3QW45aEw2bVFhYk56VW9YMjJUM21kc3puNjdNdTdwRjZsR0J6UWRpNDVWWVlfVlRiWXQxZW1NTDRZbndweVpOLTkwWTV6NWg4VGpVclBkeDJxMEdMaXFFbmd2MzN1Q0hiUkIzX1A3azhMRk9HSWQ5Q290MjNiNTNqOVJnTlZPN25sZnUtdDRiY0ljZXRKWktISDhCMEVUOHBsTnpnbE9rWjUwZmlXT1RXMXc?oc=5", "source_name": "PR Newswire", "published_at": "2024-06-20T07:00:00+00:00", "published_display": "20 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ascentage pharma campus in china reveals parametric facades inspired by chemical bonds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNTVCTEQ3c3JlUkxJV3Q5N2pFMmlCRno5c2pXTVdvc2lsaHhQcGJGbVFiMGpDMm1SajNDX2I2WThabnlpWTFvTloydjljWHM3YmdmUmIwSWdwRGdWeUtMbEdwT2tjbnV4ZGgxUkMzMDQzTUVWNUx0THI3eElNV2YxVjBKUS01QndJbzU3YnQxNUEtWVEwNDZSSVl1QmZRM01EdUdXY3RPUWh0eGpVY3luYTRnMFlqWHVxd1Y3ZEVkSzh5dw?oc=5", "source_name": "Designboom", "published_at": "2023-08-10T07:00:00+00:00", "published_display": "10 Aug 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Ascentage Pharma (AAPG) Edges Higher, Testing Key Resistance Zone - Trend Reversal Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMGQ5OVpkTW4tNjFIOWVLa1VqSlByU1N4Q29qU3gxUXdzbS1ua2o3SzhZWTNkamJ3WXRTN0l0anZnb0NSTEtrV0IwZmxtdEQtc0xnajVBWkpXSlp2YVV1YmhfamNxOGhKSXdGVkk5b2xYX25oYWJBOHIzWldMV3U0aUpqZWk0NlhleURyTU1PM2UxNFo4a1E1NHI1V1ZkaFp6YkZkejNXZXRoa3o2SFE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-09T18:40:40+00:00", "published_display": "09 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxObHU0RE1IRWdidDZJYmZhR1JNcnl2MXY3TUVwMVFSa1E0TURieGM1Ym1mNmJLT0dVQy1DY3BNUGROcjlXSDVYMmdmWlVKcExJenA3SWpkTWdPSTVkMXdacTRUWjltS1ZKX2plX2wxMmZiZFZpYjAxelZCZ2k2N2poNjZ6SEhVWmNNZkQwemtwVXVZZG8ySXdCel9qWGV3QV96dk9iWno5eWlhZDVFcmY5SXg5Y25FRno1U2VWUWd5eEU5VS1ZSXB3SVQ2Mmw0NTZqX0xZZDlfZ2dHdnpQbzhtbnhjU2o1Ukh5a29PcnJyS003dw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-07-09T13:03:00+00:00", "published_display": "09 Jul 2026 13:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPYWRNdzRqN1Z2STE1cnNSNnBtbGhDVWprWmxyYnRIX1RjekhKY0wwTmhlMFVXSFZGWTJwczVuMEFRNG5tcmxrakJaZWE2MkIzaWl3cHFuVW4tNzBGcmFCT2J2TmkxdDFQU1BkeXhZY3ZDVldFT0dxMkN5SHFzT1o3MGZ0UlRQRllGaWgtNGhQcVhrSHJGM2tEQUR5eWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQSHB1TVdpZVBQUTZxaDlWQjQtVnFLUmZ3SUVNbk95RW1GRHhoUndfaGt2NUdkUE1BbWgtRERWYk0yUG5RdUN2X1FmMFFyWEFtcDYzT0k2QWlRdjBPdFdKSFAyU2MzNG8tRExwdFNiUl9ESzVGWHRKQXhBU3g1SUxGM01ma1VsZlpsNTRFRE5oWmstUFFtQy1aSVRvdmpYZURvZEQwWnZfNHBfNDNYRXR3SDVSZDJZZHBYR1RKclhvMHpkaVdla0pZbTZtNkRneVpEdXdqdG9zYjdIQTJsWWh0MW1B?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International Unsponsored ADR Actuals & Estimates (NASDAQ:AAPG)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPQkZlUGtnSXIxNHQ0Y2pVbkh6R2I1djN2YUxKSU43QU0yZzgxbkFYTjB6MVVhR2UzY0NOem5iTlZ2Z0ZuWXJoVTltS3ItSG9wOUQ5X2c4c0Z0N0JDUFY3clYtMFgzVzM2YlMwS3RyVjNjRFMxNjNXS3RRMi1nN1dwY1dtM1lGQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T08:27:26+00:00", "published_display": "26 Jun 2026 08:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (AAPG) Hovers Near Resistance as Traders Await Catalysts - NAAIM Exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQeGhJa2UtY28wQ0oxYmtmNW5sTEZURlc3bFdiUmVvN2dWZXBTMHVXNFRXaWE4Ym5ESC1ybndJN2VrOEpfdnNndktVeE9sdHZyUnJCQTNkVHFldEdLZFA5bnU4eGxTNzdKbGJabGZDenFYTExsNkJ1dldHTC05TGRjMmVlQ2t5NnVTam83YWJkeTVMVHEtZEEyS0M4VnRWTVlBcE9nTU1wMjg4NklHNXJXWjFzVUQ2dw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-multiple-clinical-233000837.html", "source_name": "GlobeNewswire", "published_at": "2026-06-14T23:30:00+00:00", "published_display": "14 Jun 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B. Riley Initiates Ascentage Pharma Group International at Buy With $45 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/b-riley-initiates-ascentage-pharma-113838263.html", "source_name": "MT Newswires", "published_at": "2026-06-10T11:38:38+00:00", "published_display": "10 Jun 2026 11:38", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNLVg3MHdZSkRGQUc1QkV2SUdwcmdraEU4Y0ZZa3NKODZ5Ml94RTVhUHcyMDBMcllCQ2Fma19uLXREV3NKSkhFeWtFRXFQRVVPWktVTXpwdDZoY3hFZUEzUVk2SGl3eUozOXlweXI1UmVMMklWNHJYdFNqSlhadHNhZ2xLT3RqdzNoRjZzempIajNWM1ctNGtvVkNzY0hvcFFJdzdtdG9pUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-data-olverembatinib-233000707.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-first-dataset-233000569.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/ascentage-pharma-presents-updated-clinical-233000091.html", "source_name": "GlobeNewswire", "published_at": "2026-05-31T23:30:00+00:00", "published_display": "31 May 2026 23:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNMjgwWWlCbjR2U0V4eVpZc0FLMG9OSWoxcldJY1BCaWNEbnNjSUo3dHZKanNqQktpWmo0VnpNYlQxMTk1WFRjNjFXdnd6Wm5EWDA1Wkt1V0dZX1p6UHBxQmc1ZVZENzVONXFJLV9TM0V5UWVBMUxkSjczeUgyM0xxSEpsdFk5ZldTRVV2eHM5elhpcndhaVNFdGJQaWg5R2owbER2WjAteU42S3E2OThjWjJNd2wyaEhObWVQeUZBeUFsQW01d0ZEYjczQXFCU0lDdHVrN0hmRFRUVWlhaVRmZFRXQXlfMTQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma: Interview With Co-Founder & CEO Dr. Dajun Yang About The Global Hematology-Oncology Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1uMVItSWJpa1BJUS1SNWczVXY4YS1xMjg2THF4VTJsdG9WaWRLSF84UnFPWkVNallRZWlrMU1hQ1MwLU1QVmZ3aUEyZnFJR3lhejNBX3dmaUtfN3EyMmhSbkg4UVFWRmc4WGVCNlYzOWttY0xCRWZV0gF8QVVfeXFMUHpYYnpoLWxqc2Z1WTZGSDBDTXIxWjVGZ3NMNFZValZQMnVUamcxdkVsb1lHRVhMZERFdFFpV1ZTY0JRdG9OMGZINnBfeWJmN1QzT0szUnktaTd0UTB1b2pYTksyMlVzUk8xQmRIWVp1dTBVY2x2YUtYeGEzVA?oc=5", "source_name": "Pulse 2.0", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMkx3dXpVekVwcXpzNFFqZlRDdlE2dkliMGJGVUxld1BqZjhVLUt5aVJzVERaZjlMM0lJQ1RnTlRYb2pMLVpFd29ELWNlcks2U1JIMUNOUmRpNHJKY3hIcFE0Q2ZVRk9vbDZvNnEtMHpKdlRWRkdONEItbHUtaWFEVGZFOFN2cXNSZzVKZUhiRmVuUVcwdHgxOERqcGVleWljVjVEaThR?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAJBVV95cUxQZjJFWnc5cjFaTkR0R0xaeTFVVWRGS1BfNHdzbmh0SUFYdTJNSEJDR0pneGNfUTViTlpvSVVrTVlpXzU2ZEVFdGJFME5Gdll5VGFGdzBiMWxCUDZlYVVZdGtvQk55RWhBOFdfc09sZ2kxNnU5X244RGNFYnJNRDF5dEo1UE1hci1CVzZyeDZneWlLWTNXUHJjVXZnc1phWmRJRkVjNEJUTnFzRVNnYU5VZWxEMm9IVmhFWTJyeTF6TV9mSlh6ZUVvWlV5Q3NOc2pWaVFwTl9iYmJldUZocUJJTTJqUEo2TnN6cHRjT3hPWXJuZl9FLU5MbXJfRTFpSzNoQkVHdW9Oa3NwT0Q3RTJGc0V5T0xycThSMkZRUUU4eTh3T3RyQ1Y0bm01TFBGc3dXV0FxNlAzVmtoRjFvaEFjdm9Zblc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYSnZYMURPZEpZNW90bEZrSkNzNWp4aHVRT1hMRkxUN25wRi1nZFlNYWpCSEpiS0JNNFh2YmctQnlCT3VlN0hNQnpUdDM2U3BaMzRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T15:42:33+00:00", "published_display": "25 Apr 2025 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQeW5MS1NkQUtUTHBMRlRpaUdmRVVSR0twQU5kVnlNR0txMWZrbVF2MThLZkcyQ1FDbHhIdWNuaVhUQ29jUUZxZW1YNWQxU2J6dXlwOEU5V1gzQkJPZWM4a200Nlc5elBZWnMxMnBOOWdORWdkQlIwVUhSOE1wV3czbmJtR21oYzA?oc=5", "source_name": "Market source", "published_at": "2025-03-27T07:00:00+00:00", "published_display": "27 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Ascentage Pharma Group International - Unsponsored ADR (AAPG)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE16eGJ1dEJoYkRNb2lFQ096RVdfSWsxcmNaZHlmNWU2eFh5d1JybXpMQzFFTElzM0NkTVNNWXhIbHFidmVzOWdiYVBSR0JhRndXOEJheUU5VW94R3YzdEFGajJFamUyR0dsbDdwZHdIT3lvLVNaZWh3bg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-02-26T00:20:12+00:00", "published_display": "26 Feb 2025 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1ZLVhpaW5CWFNMUlBvUlpsMm51TER1VmJ2Z0swQ3VrMjY0ZWN6eTBEZDRIMEVZMjBiZExDUzlNcGdJS0pBaERrZWtORTRBYmNLWTE3UVpVeUNHMFdRTFhmaGJKaEplQQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-02-08T15:07:42+00:00", "published_display": "08 Feb 2025 15:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage prices first biotech IPO of 2025, raising $126M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMUNPSEJxZVpOa3RUMm80SGJBSXozeGxrd2UtU19JZUMyRnV0bzRJRGNkVHJraG5rbC1fR1gyT2tCREtvcGdhYmtYTVlfMy1JMlZ3X0ZmZG9ZWlgycWZGaVpqTW1NbHE0VTlXMklUN1JTVkxjbXhVVi1KRlJHM3RmMjMycVFuZ0ZLZGhn?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma soars on deal with cancer drug competitor", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPUHRFcWJ1QkNzUDNPUGVjbkNkbng5Ty1oSG1adl9jRWpiZTBHR0tiVzJrTEhySFZReTAyTHc5OXg2NU5NTmFzaEt0RWUwZkxmYlVVWlpOVVhENFNrWTVxT1Fnck9aNDJzU2l2ZmRjZnltaExBaWlEenZwTG5zRDQxVGwyZnE3SFJpZTBRNWd5VQ?oc=5", "source_name": "thebambooworks.com", "published_at": "2024-06-27T07:00:00+00:00", "published_display": "27 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQaFZ5b0V4Z0tpX1ZOdXpHZTFPbk96QzJLYVFJang3QW45aEw2bVFhYk56VW9YMjJUM21kc3puNjdNdTdwRjZsR0J6UWRpNDVWWVlfVlRiWXQxZW1NTDRZbndweVpOLTkwWTV6NWg4VGpVclBkeDJxMEdMaXFFbmd2MzN1Q0hiUkIzX1A3azhMRk9HSWQ5Q290MjNiNTNqOVJnTlZPN25sZnUtdDRiY0ljZXRKWktISDhCMEVUOHBsTnpnbE9rWjUwZmlXT1RXMXc?oc=5", "source_name": "PR Newswire", "published_at": "2024-06-20T07:00:00+00:00", "published_display": "20 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ascentage pharma campus in china reveals parametric facades inspired by chemical bonds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNTVCTEQ3c3JlUkxJV3Q5N2pFMmlCRno5c2pXTVdvc2lsaHhQcGJGbVFiMGpDMm1SajNDX2I2WThabnlpWTFvTloydjljWHM3YmdmUmIwSWdwRGdWeUtMbEdwT2tjbnV4ZGgxUkMzMDQzTUVWNUx0THI3eElNV2YxVjBKUS01QndJbzU3YnQxNUEtWVEwNDZSSVl1QmZRM01EdUdXY3RPUWh0eGpVY3luYTRnMFlqWHVxd1Y3ZEVkSzh5dw?oc=5", "source_name": "Designboom", "published_at": "2023-08-10T07:00:00+00:00", "published_display": "10 Aug 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 81, "total_relevant": 33, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 28, "score": 52, "total": 33, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 10.8, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 19.97, "latest_week": "2026-07-10", "one_week_move": 7.9, "four_week_move": 13.5, "twelve_week_move": -27.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.551132, "market_dynamics_buy_signal": false, "relative_strength": -42.281142, "fair_value_gap": -27.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.8092, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+7.9% over one week, +13.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "GlobeNewswire", "count": 6}, {"label": "Zacks Investment Research", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Donan\u0131mHaber", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "dars.gov.et", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 10}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+7.9% over one week, +13.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Ascentage Pharma (AAPG) Edges Higher, Testing Key Resistance Zone - Trend Reversal Picks"}], "updated_at": "2026-07-16T10:52:59.544264+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}